Fedratinib and Avanafil: Interaction Details
- Fedratinib
- Inrebic
- Avanafil
- Stendra
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fedratinib and Avanafil interaction:
What Happens When You Take Fedratinib With Avanafil
What can happen when they are taken together (rated Major)
Increased exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Because fedratinib inhibits CYP3A4, giving it together with CYP3A4 substrates can raise the concentrations of those substrates and heighten their risk of adverse reactions. Single-dose studies showed that fedratinib raised the of midazolam, a CYP3A4 substrate, 4-fold. When the drugs must be coadministered, patients should be monitored for adverse reactions, and the dose of any CYP3A4 substrate should be adjusted.1
The Fedratinib and Avanafil Interaction, Explained
Fedratinib can raise the amount of avanafil in your body. Fedratinib slows down , a liver enzyme that normally breaks avanafil down. With less breakdown, avanafil can build up, which may mean stronger effects and more side effects such as headache, flushing, dizziness, or low blood pressure. In a study with a different drug cleared the same way, fedratinib raised its levels about 4-fold.
This is considered a major interaction, but it can be managed. Keep taking your medicines as prescribed and ask your pharmacist or doctor before using avanafil. They may adjust the dose and check on you more closely.
Mechanism: Fedratinib inhibits , and avanafil is a CYP3A4 (the active parent drug, not a ). Expect increased avanafil exposure (, ) and greater PD effects.
- Magnitude: Not studied with avanafil. Fedratinib increased midazolam AUC about 4-fold in single-dose PK studies.
- Risk: , headache, flushing, dizziness, and other PDE5 adverse effects.
- Onset: Unspecified. Evidence: Probable. Severity: major.
- Management: If is necessary, monitor for adverse reactions and adjust the avanafil dose. Individualize, and consider the labeled avanafil limits with CYP3A4 .
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fedratinib and Avanafil Interact
The likely mechanism
of -mediated by fedratinib
How to Manage the Fedratinib and Avanafil Interaction
Your care team can manage this by tailoring the dose and monitoring you.
- Keep taking fedratinib as prescribed, and do not start avanafil without checking first.
- Your prescriber may adjust the avanafil dose and may monitor you more closely for side effects.
- Tell your pharmacist or doctor about all your medicines, including supplements.
- Report dizziness, fainting, a racing heartbeat, severe headache, or an unusually strong reaction to avanafil promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fedratinib or Avanafil need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: INREBIC oral capsules, fedratinib oral capsules
When a single 2 mg dose of midazolam (a ) was given together with fedratinib, the midazolam rose 4-fold.1
Fedratinib and Avanafil: Common Questions
How serious is the Fedratinib and Avanafil interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fedratinib and Avanafil interaction managed?
Your care team can manage this by tailoring the dose and monitoring you. Keep taking fedratinib as prescribed, and do not start avanafil without checking first. Your prescriber may adjust the avanafil dose and may monitor you more closely for side effects. Tell your pharmacist or doctor about all your medicines, including supplements. Report dizziness, fainting, a racing heartbeat, severe headache… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fedratinib and Avanafil Interaction
Ask in your own words about taking Fedratinib and Avanafil together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: INREBIC(R) oral capsules, fedratinib oral capsules. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2023. DailyMed
Other Serious Interactions of Fedratinib and Avanafil
Also serious with Fedratinib
Also serious with Avanafil
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Avanafil
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- HawthornMajor
- American MistletoeMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- + 141 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.